Systemic AA-amyloidosis is a protein-misfolding disease characterized by fibril deposition of serum amyloid-A protein (SAA) in several organs in humans and many animal species. Fibril deposits originate from abnormally high serum levels of SAA during chronic inflammation. A high prevalence of AA-amyloidosis has been reported in captive cheetahs and a horizontal transmission has been proposed. In domestic cats, AA-amyloidosis has been mainly described in predisposed breeds but only rarely reported in domestic short-hair cats. Aims of the study were to determine AA-amyloidosis prevalence in dead shelter cats. Liver, kidney, spleen and bile were collected at death in cats from 3 shelters. AA-amyloidosis was scored. Shedding of amyloid fibrils was investigated with western blot in bile and scored. Descriptive statistics were calculated. In the three shelters investigated, prevalence of AA-amyloidosis was 57.1% (16/28 cats), 73.0% (19/26) and 52.0% (13/25), respectively. In 72.9% of cats (35 in total) three organs were affected concurrently. Histopathology and immunofluorescence of post-mortem extracted deposits identified SAA as the major protein source. The duration of stay in the shelters was positively associated with a histological score of AA-amyloidosis (B = 0.026, CI95% = 0.007–0.046; p = 0.010). AA-amyloidosis was very frequent in shelter cats. Presence of SAA fragments in bile secretions raises the possibility of fecal-oral transmission of the disease. In conclusion, AA-amyloidosis was very frequent in shelter cats and those staying longer had more deposits. The cat may represent a natural model of AA-amyloidosis.
AA-amyloidosis is frequent in shelter cats, and chronic kidney disease is the foremost cause of death. The aims were to describe kidney laboratory and microscopic findings in shelter cats with AA-amyloidosis. Cats were included if kidney specimens were collected post-mortem and laboratory data were available within 6 months before death. Renal lesions were evaluated with optical and electron microscopy. Mass spectrometry was used to characterize amyloid. Nine domestic short-hair cats were included; 4 females and 5 males with a median age of 8 years (range = 2–13). All cats had blood analyses and urinalyses available. Serum creatinine concentrations were increased in 6 cats and symmetric dimethylarginine was increased in all of the cats. All of the cats had proteinuria. Eight of 9 cats had amyloid in the medulla, and 9 had amyloid in the cortex (glomeruli). All cats had amyloid in the interstitium. Six cats had concurrent interstitial nephritis and 1 had membranoproliferative glomerulonephritis. All cats had extrarenal amyloid deposits. Amyloid was AA in each case. In conclusion, renal deposition of amyloid occurs in both cortex and medulla in shelter cats and is associated with azotemia and proteinuria. Renal involvement of systemic AA-amyloidosis should be considered in shelter cats with chronic kidney disease. The cat represents a natural model of renal AA-amyloidosis.
Systemic AA-amyloidosis is a protein-misfolding disease that is characterized by fibril deposition of serum amyloid-A protein (SAA) in several organs in humans and many animal species. Fibril deposits originate from abnormally high serum levels of SAA during chronic inflammation. In domestic short-hair cats, AA-amyloidosis has only been anecdotally reported and is considered a rare disease. Here we report that an astonishing 57-73% of early deceased short-hair cats kept in three independent shelters suffer from amyloid deposition in the liver, spleen, or kidney. Histopathology and mass spectrometry of post-mortem extracted deposits identified SAA as the major protein source. The duration of stay in the shelters was positively associated with a histological score of AA-amyloidosis (B=0.026, CI95%=0.007-0.046; p=0.010). Presence of SAA fragments in bile secretions raises the possibility of fecal-oral transmission of the disease.
Pancreatitis is frequently found microscopically in cats with different diseases, particularly diabetes mellitus. Whether pancreatic inflammation is associated with morphological alterations in the endocrine pancreas before the development of diabetes remains unclear. We investigated the relationship between the endocrine pancreas and pancreatic inflammation based on the histology and circulating markers of pancreatitis in non-diabetic cats. The study included 60 cats without diabetes that had been euthanized for different diseases. None of the cats were euthanized for the purposes of this study. The serum 1.2-o-dilauryl-rac-glycero-3-glutaric acid-6-methylresorufin ester (DGGR)-lipase activities and feline pancreas-specific lipase concentrations were measured within 12 h before euthanasia. Immunohistochemistry was performed on pancreatic samples for insulin, glucagon, CD3 (T-lymphocytes), CD20 (B-lymphocytes), Iba-1 (macrophages) and myeloperoxidase (neutrophils). Insulin- and glucagon-positive cross-sectional areas were quantified as percentages of the pancreatic tissue area analyzed. Acute and chronic pancreatitis, pancreatitis activity index, and inflammatory cells were assessed. A negative correlation was observed between the glucagon-positive area and (i) DGGR-lipase (r = −0.426, CI95% = −0.633 to −0.163; p = 0.002) and (ii) pancreatitis activity index (r = −0.440, CI95% = −0.643 to −0.179; p = 0.001). Smaller glucagon-positive areas were found in cats with marked macrophage infiltration in the exocrine pancreas compared to those with few or no macrophages [median = 0.08% (range = 0.03–0.20) vs. 0.15% (0.03–0.53); p = 0.001]. Glucagon-positive areas did not differ between cats with and without acute and chronic pancreatitis. The insulin-positive area did not differ among cats with different lipase activities and the histological criteria for pancreatitis. In conclusion, a negative association was found between pancreatic inflammatory activity and glucagon-positive cross-sectional area, but not insulin-positive cross-sectional area, in non-diabetic cats. Whether this relationship reflects a causal effect of inflammation on α-cells or whether both changes occur concurrently cannot be determined from this cross-sectional study.